Foundational Science
New tools are changing what we can discover, measure, and build
Foundational Science is the translation of advances in biology, quantum computing, materials science and space research into tools for research, diagnostics and drug development. Averin Capital, an early-stage venture capital firm in New York, invests in companies turning those advances into new ways to understand and treat disease.
- Focus 01
- AI & computation
- Focus 02
- Precision medicine
- Focus 03
- Discovery platforms
- Focus 04
- Novel materials
What we invest in
Advances in biology, quantum computing, materials science, and research in space can change how we understand and treat disease. We invest in companies turning those advances into tools for research, diagnostics, and drug development.
How we work with founders
Averin’s partners have built and run companies. We help founders with operating choices, anticipate challenges, and connect them with the people who matter across technology, science and healthcare.
Our partnerships rest on candid communication, mutual trust, forward planning and execution informed by data and specialist networks.
Questions
Does Averin Capital invest in Foundational Science?
Yes. Foundational Science is one of Averin’s five investment areas, alongside Physical Intelligence, Care Delivery, Healthcare Infrastructure and Human Performance.
What stage does Averin invest in?
Averin invests from pre-seed through later stages and also creates companies. Typical initial investments range from $500,000 to $10 million, and Averin sometimes leads rounds.
Where does Averin invest?
Averin is based in New York and invests in companies in the United States, Europe and Asia.
Does a company need to use AI to fit?
No. AI is a capability that runs across Averin’s areas, not a requirement for every investment.
Other areas
-
-
-
-
Building in Foundational Science?
Tell us what you’re working on Read Perspectives